SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-05-024223
Filing Date
2005-05-18
Accepted
2005-05-18 08:30:27
Documents
3
Period of Report
2005-05-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a05-9577_18k.htm 8-K 30699
2 EX-10.1 a05-9577_1ex10d1.htm EX-10.1 365762
3 EX-99.1 a05-9577_1ex99d1.htm EX-99.1 21588
  Complete submission text file 0001104659-05-024223.txt   419651
Mailing Address 119 FOURTH AVE NEEDHAM MA 021942725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
AVANT IMMUNOTHERAPEUTICS INC (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-15006 | Film No.: 05840221
SIC: 2835 In Vitro & In Vivo Diagnostic Substances